Complete Filing Data
Metal Sky Star Acquisition Corp reported Stockholders Equity of -$8.22 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Metal Sky Star Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$553.6K | $923.1K | $2.2M | $1.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$553.6K | $923.1K | $2.2M | $1.3M |
| Operating Expenses | $670.7K | $802.9K | $798.5K | $398.8K |
| Nonoperating Income Expense | $117.1K | $1.7M | $3.0M | $1.7M |
| Operating Income Loss | -$802.9K | -$798.5K | -$398.8K | |
| Interest Income Expense Net | $1.3M | |||
| Income Loss From Continuing Operations | -$398.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$92.7K | -$198.0K | -$153.2K | $144.1K | $392.2K | $297.0K | $662.4K | $466.4K | $595.5K | $409.8K | -$7.7K | -$3.6K | -$3.9K | -$11.8K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$92.7K | -$198.0K | -$153.2K | $144.1K | $392.2K | $297.0K | $662.4K | $466.4K | $595.5K | $409.8K | -$7.7K | -$3.6K | -$3.9K | -$11.8K |
| Operating Expenses | $101.9K | $225.9K | $223.8K | $329.6K | $74.1K | $161.8K | $110.6K | $224.0K | $263.4K | $110.1K | $168.6K | $3.9K | $11.8K | |
| Nonoperating Income Expense | $9.2K | $27.9K | $70.6K | $473.7K | $466.3K | $458.8K | $773.0K | $690.4K | $858.9K | $519.9K | $160.9K | |||
| Operating Income Loss | -$223.8K | -$329.6K | -$74.1K | -$161.8K | -$110.6K | -$224.0K | -$263.4K | -$110.1K | -$168.6K | -$3.6K | -$3.9K | -$11.8K | ||
| Interest Income Expense Net | $516.0K | $448.8K | $636.1K | $298.9K | $77.6K | |||||||||
| Income Loss From Continuing Operations | -$110.6K | -$224.0K | -$110.1K | -$168.6K | -$3.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$8.2M | -$7.2M | -$5.8M | -$2.8M | $150.00 |
| Liabilities Current | $5.3M | $4.3M | $2.8M | $146.7K | $332.4K |
| Liabilities | $8.2M | $7.2M | $5.7M | $3.0M | $332.4K |
| Assets | $1.0M | $6.7M | $35.4M | $116.9M | $332.5K |
| Liabilities And Stockholders Equity | $1.0M | $6.7M | $35.4M | $116.9M | $332.5K |
| Common Stock Value | $3.2K | $3.2K | $3.2K | $3.2K | $2.9K |
| Accrued Liabilities Current | $574.5K | $400.3K | $298.3K | $146.7K | $800.00 |
| Retained Earnings Accumulated Deficit | -$8.2M | -$7.2M | -$5.8M | -$2.8M | -$24.9K |
| Marketable Securities Unrealized Gain Loss | $3.2K | $36.1K | $155.9K | $377.7K | |
| Assets Current | $20.3K | $6.3K | $1.9K | $218.3K | $332.5K |
| Marketable Securities Noncurrent | $1.0M | $6.7M | $35.4M | $116.7M | |
| Liabilities Noncurrent | $2.9M | $2.9M | $2.9M | $2.9M | |
| Deferred Underwriting Commissions | $2.9M | $2.9M | $2.9M | $2.9M | |
| Assets Noncurrent | $1.0M | $6.7M | $35.4M | $116.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $178.7K | $96.0K | |||
| Temporary Equity Carrying Amount Attributable To Parent | $1.0M | $6.7M | $35.4M | $116.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |||||
| Cash Withdrawn From Trust Account To Redeem Public Shares | 6.1M | 31.1M | 86.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$178.7K | $82.7K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $82.7K | ||||
| Notes Payable Current | $3.2M | $2.8M | |||
| Cash Held In Escrow | $96.0K | ||||
| Other Liabilities Current | $1.6M | $1.1M | |||
| Temporary Equity Value Excluding Additional Paid In Capital | |||||
| Unrealized Gained On Marketable Securities Held In Trust Account | |||||
| Marketable Securities Current | |||||
| Deferred Underwriting Commission | |||||
| Deferred Offering Costs | $236.5K | ||||
| Accrued Offering Costs | $31.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$8.0M | -$7.8M | -$7.5M | -$6.8M | -$6.3M | -$6.1M | -$5.3M | -$4.6M | -$3.8M | -$2.7M | -$2.6M | -$3.4K | $9.4K | $13.3K | |||
| Liabilities Current | $5.2M | $5.0M | $4.7M | $3.9M | $3.5M | $3.3M | $5.3M | $4.7M | $4.0M | $3.0M | $2.9M | $415.0K | |||||
| Liabilities | $8.1M | $7.8M | $7.6M | $6.8M | $6.4M | $6.1M | $5.3M | $4.7M | $4.0M | $3.0M | $2.9M | $415.0K | |||||
| Assets | $984.4K | $863.2K | $7.0M | $37.3M | $36.7M | $36.1M | $60.8M | $59.5M | $58.3M | $115.9M | $115.5M | $411.6K | |||||
| Liabilities And Stockholders Equity | $984.4K | $863.2K | $7.0M | $37.3M | $36.7M | $36.1M | $60.8M | $59.5M | $58.3M | $115.9M | $115.5M | $411.6K | |||||
| Common Stock Value | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $2.9K | |||||
| Accrued Liabilities Current | $528.5K | $507.4K | $455.5K | $408.8K | $330.3K | $404.8K | $303.5K | $290.7K | $289.1K | $79.6K | $59.8K | $3.6K | |||||
| Retained Earnings Accumulated Deficit | -$8.0M | -$7.9M | -$7.5M | -$6.8M | -$6.3M | -$6.1M | -$5.3M | -$4.6M | -$3.8M | -$2.7M | -$2.6M | -$28.4K | |||||
| Marketable Securities Unrealized Gain Loss | $3.0K | $2.8K | $24.4K | $142.2K | $154.7K | $157.1K | $257.0K | $241.6K | $222.9K | ||||||||
| Assets Current | $63.4K | $1.4K | $67.3K | $29.1K | $45.6K | $600.00 | |||||||||||
| Marketable Securities Noncurrent | $921.0K | $861.8K | $6.9M | $37.3M | $36.7M | $36.1M | |||||||||||
| Liabilities Noncurrent | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | |||||||||||
| Deferred Underwriting Commissions | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | ||||||||||
| Assets Noncurrent | $921.0K | $861.8K | $6.9M | $37.3M | $36.7M | $36.1M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.2K | $1.2K | $132.4K | ||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $946.0K | $861.8K | $6.9M | $37.3M | $36.6M | $36.0M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.2K | $1.2K | $132.4K | $178.7K | $188.4K | $244.6K | $54.1K | $96.0K | $221.1K | $325.0K | |||||||
| Cash Withdrawn From Trust Account To Redeem Public Shares | 60.1M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$46.3K | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$46.3K | -$41.9K | $325.0K | ||||||||||||||
| Notes Payable Current | $3.1M | $3.0M | $3.0M | $2.7M | $2.6M | $2.4M | $2.2M | ||||||||||
| Cash Held In Escrow | $1.2K | $1.2K | $132.4K | $178.7K | $188.4K | $244.6K | $54.1K | ||||||||||
| Other Liabilities Current | $1.5M | $1.4M | $1.3M | ||||||||||||||
| Temporary Equity Value Excluding Additional Paid In Capital | $60.8M | $59.5M | $58.2M | $116.7M | $115.7M | $115.2M | |||||||||||
| Unrealized Gained On Marketable Securities Held In Trust Account | $257.0K | $241.6K | $222.9K | $221.0K | $83.3K | ||||||||||||
| Marketable Securities Current | $60.8M | $59.5M | $58.2M | $116.7M | $115.7M | $115.2M | |||||||||||
| Deferred Underwriting Commission | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | ||||||||||||
| Deferred Offering Costs | $357.5K | ||||||||||||||||
| Accrued Offering Costs | $111.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -$5.8M | -$30.4M | -$84.2M | $115.2M |
| Increase Decrease In Accrued Liabilities | $174.3K | $102.0K | $151.5K | $145.9K |
| Payments To Acquire Investments | $350.0K | $650.0K | $2.1M | $115.0M |
| Net Cash Provided By Used In Investing Activities | $5.8M | $30.4M | $84.3M | -$115.0M |
| Increase Decrease In Prepaid Expense | $139.6K | $70.8K | $63.1K | $157.5K |
| Net Cash Provided By Used In Operating Activities | -$233.3K | -$87.6K | ||
| Proceeds From Related Party Debt | $350.0K | $650.0K | $2.2M | |
| Increase Decrease In Accrued Offering Costs | -$31.6K | |||
| Proceeds From Issuance Of Private Placement | $3.3M | |||
| Payments For Repurchase Of Common Stock | $6.1M | $31.1M | $86.4M | |
| Increase Decrease In Due To Related Parties Current | $510.4K | $705.3K | $375.8K | |
| Proceeds From Issuance Of Common Stock | $114.7M | |||
| Increase Decrease In Deferred Offering Costs | -$236.5K | |||
| Increase Decrease In Deferred Charges | -$236.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | $150.0K | $250.0K | -$59.3M | $325.0K | |
| Increase Decrease In Accrued Liabilities | $55.2K | $106.5K | $142.4K | $11.8K | |
| Payments To Acquire Investments | $150.0K | $250.0K | $757.7K | ||
| Net Cash Provided By Used In Investing Activities | -$150.0K | -$250.0K | $59.3M | ||
| Increase Decrease In Prepaid Expense | $86.3K | $600.00 | |||
| Net Cash Provided By Used In Operating Activities | -$82.2K | -$41.9K | |||
| Proceeds From Related Party Debt | $150.0K | $250.0K | $793.6K | $300.0K | |
| Increase Decrease In Accrued Offering Costs | $82.7K | ||||
| Proceeds From Issuance Of Private Placement | |||||
| Payments For Repurchase Of Common Stock | $60.1M | ||||
| Increase Decrease In Due To Related Parties Current | $229.7K | $54.0K | |||
| Proceeds From Issuance Of Common Stock | |||||
| Increase Decrease In Deferred Offering Costs | $121.0K | ||||
| Increase Decrease In Deferred Charges |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 3.2M | 3.2M | 3.2M | 3.2M | 2.9M |
| Temporary Equity Shares Outstanding | 60.5K | 552.5K | 3.2M | 11.5M | 11.5M |
| Common Stock Shares Issued | 3.2M | 3.2M | 3.2M | 3.2M | 2.9M |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Temporary Equity Redemption Price Per Share | $17.02 | $12.09 | $11.06 | $10.15 | |
| Basic And Diluted Net Loss Per Share | |||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption | 8.5M | ||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Not Subject To Possible Redemption | 3.1M | ||||
| Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption | $0.75 | ||||
| Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | |||
| Temporary Equity Shares Outstanding | 60.5K | 60.5K | 552.5K | 3.2M | 3.2M | 3.2M | 5.6M | 5.6M | 5.6M | 11.5M | 11.5M | |||
| Common Stock Shares Issued | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | |||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Temporary Equity Redemption Price Per Share | $15.63 | $14.24 | $12.49 | $11.63 | $11.44 | |||||||||
| Basic And Diluted Net Loss Per Share | $-0.08 | $-0.09 | $-0.10 | $-0.01 | $-1.34 | $0.00 | $0.00 | $0.00 | ||||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption | 5.6M | 5.6M | 7.1M | 11.5M | 11.0M | |||||||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Not Subject To Possible Redemption | 3.2M | 3.2M | 3.2M | 2.5M | 2.9M | 2.9M | ||||||||
| Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption | $0.16 | $0.13 | $0.13 | $0.04 | $0.39 | |||||||||
| Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares | 3.2M | 3.2M | 3.2M | 3.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension | -375.0K | -600.0K | -3.0M | ||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned On Trust Account | -117.1K | -1.7M | -2.2M | -1.7M | |
| Formation And Operational Costs | $670.7K | $802.9K | $798.5K | $398.8K | |
| Adjustment For Amortization | $125.6K | $66.4K | $100.9K | $117.8K | |
| Interest Income Operating | $113.9K | $1.7M | $2.8M | $1.3M | |
| Prepaid Expense Current | $20.3K | $6.3K | $1.9K | $39.7K | |
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned Unrealized Gain On Trust Account And Additional Funding For Business Combination Extension | 117.1K | 2.3M | 5.1M | ||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account | -1.7M | ||||
| Stock Issued During Period Value New Issues | $50.0K | $115.0M | |||
| Escrow Deposit | $178.7K | ||||
| Prepaid Insurance | |||||
| Reclassification Of Offering Costs Related To Public Shares | -5.0M | ||||
| Net Investment Income | $113.9K | $1.7M | |||
| Interest Earned In Trust Account | $1.3M | ||||
| Change In Value Of Ordinary Shares Subject To Redemption | 18.8M | ||||
| Additional Paid In Capital | $22.1K | ||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemptions Interest Earned On Trust Account | 5.1M | 1.7M | |||
| Defer Underwriting Compensation | $2.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension | -75.0K | -75.0K | -150.0K | -473.7K | -150.0K | -150.0K | -561.4K | -561.5K | -757.7K | |||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned On Trust Account | -9.2K | -27.9K | -70.6K | -150.0K | -466.3K | -458.8K | -773.0K | -690.4K | -858.9K | -519.9K | -160.9K | |||
| Formation And Operational Costs | $101.9K | $225.9K | $223.8K | $329.6K | $74.1K | $161.8K | $110.6K | $224.0K | $263.4K | $110.1K | $168.6K | $3.6K | ||
| Adjustment For Amortization | $25.3K | $1.9K | $38.9K | |||||||||||
| Interest Income Operating | $46.2K | $331.5K | $311.6K | $301.8K | $516.0K | $448.8K | $636.1K | |||||||
| Prepaid Expense Current | $38.4K | $1.4K | $67.3K | $29.1K | $45.6K | $600.00 | $21.3K | $40.6K | ||||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned Unrealized Gain On Trust Account And Additional Funding For Business Combination Extension | 220.6K | 608.8K | 1.6M | |||||||||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account | -773.0K | -690.4K | -858.9K | -519.9K | -160.9K | |||||||||
| Stock Issued During Period Value New Issues | $25.0K | |||||||||||||
| Escrow Deposit | ||||||||||||||
| Prepaid Insurance | $822.00 | $39.7K | $79.4K | $113.4K | ||||||||||
| Reclassification Of Offering Costs Related To Public Shares | ||||||||||||||
| Net Investment Income | $6.2K | $25.1K | $331.5K | $311.6K | ||||||||||
| Interest Earned In Trust Account | $636.1K | |||||||||||||
| Change In Value Of Ordinary Shares Subject To Redemption | ||||||||||||||
| Additional Paid In Capital | $22.1K | |||||||||||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemptions Interest Earned On Trust Account | ||||||||||||||
| Defer Underwriting Compensation |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.